Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal

Drug maker Eli Lilly and Company and biotechnology company CureVac AG agreed to develop a series of cancer immunotherapies based on CureVac’s messenger RNA technology. . . . → Read More: Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal

Univ. Spin-Off Reports Cancer Immunotherapy Advance

A highly targeted synthetic antibody, developed by a university spin-off enterprise, was shown to destroy human breast cancer cells grafted in lab mice. . . . → Read More: Univ. Spin-Off Reports Cancer Immunotherapy Advance

Online Game Harnessed to Combat Foodborne Toxins

A consortium of companies and university labs is recruiting participants in an online computer game to design synthetic proteins to neutralize a toxin that contaminates food crops. . . . → Read More: Online Game Harnessed to Combat Foodborne Toxins

Gas-Jet Printing Process Developed for Medications

A team of material scientists and biomedical engineers designed techniques for producing pharmaceuticals on demand by printing drugs as thin films. . . . → Read More: Gas-Jet Printing Process Developed for Medications

Trial Comparing 2-D, 3-D Mammogram Outcomes

A large-scale clinical trial is underway comparing the effectiveness of two-dimensional and three-dimensional mammograms in screening for breast cancer. . . . → Read More: Trial Comparing 2-D, 3-D Mammogram Outcomes

Chip Device Finds, Collects Circulating Tumor Cells

A multi-disciplinary team designed a lab-on-a-chip device using hydrodynamic forces to find and help identify circulating tumor cells in blood samples. . . . → Read More: Chip Device Finds, Collects Circulating Tumor Cells

Guidelines Designed for CAR T-Cell Cancer Therapies

Cancer specialists and scientists at several cancer care centers propose safety guidelines for patients receiving engineered immune cell treatments that often have severe adverse effects. . . . → Read More: Guidelines Designed for CAR T-Cell Cancer Therapies

Drug Delivery Technology Licensed in $2B Deals

The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals

Wearable-Implant Diagnostics Device in Development

A university engineering lab is developing a device combining a sensor chip implanted under the skin and wrist band to diagnose serious diseases and transmit the data. . . . → Read More: Wearable-Implant Diagnostics Device in Development

Engineered T-Cell Trials Stopped after Patient Death

The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died. . . . → Read More: Engineered T-Cell Trials Stopped after Patient Death